News

Chile stops controversial sterilisation

BMJ 1995; 310 doi: https://doi.org/10.1136/bmj.310.6978.488 (Published 25 February 1995) Cite this as: BMJ 1995;310:488

Chile has stopped the controversial use of quinacrine, an antimalarial drug, to sterilise women until its properties have been fully evaluated. The technique, which entails inserting quinacrine pellets into the uterus, works by scarring the fallopian tubes and was first developed byChilean doctors. Health Minister Carlos Massad denied that the drug had been shown to have dangerous side effects but acknowledged that crucial tests relating to toxicity and mutagenicity had not been performed.

Health organisations and women's groups have argued for years that a double standard was being applied to women in the developing world who were given …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe